Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment - Trial NCT06354504
Access comprehensive clinical trial information for NCT06354504 through Pure Global AI's free database. This phase not specified trial is sponsored by Akdeniz University and is currently Completed. The study focuses on Periodontitis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Akdeniz University
Timeline & Enrollment
N/A
Nov 19, 2019
Sep 20, 2020
Primary Outcome
Gingival crevicular fluid Bactericidal/permeability-increasing proteins levels
Summary
The aim of this study was to examine the relationship between healing response after
 non-surgical periodontal treatment and baseline gingival crevicular fluid (GCF) levels of
 bactericidal/permeability-increasing protein (BPI) and interleukin-1beta (IL-1ß).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06354504
Non-Device Trial